Humana (NYSE:HUM) Hits New 52-Week High Following Analyst Upgrade

Humana Inc. (NYSE:HUM) hit a new 52-week high during trading on Friday after Wolfe Research upgraded the stock from a hold rating to a strong-buy rating. The stock traded as high as $351.88 and last traded at $345.6940, with a volume of 621921 shares trading hands. The stock had previously closed at $349.80.

Several other analysts have also recently commented on the stock. TD Cowen raised their price objective on shares of Humana from $173.00 to $211.00 and gave the company a “hold” rating in a research note on Friday, May 1st. Piper Sandler reiterated a “neutral” rating and issued a $254.00 price objective (up from $182.00) on shares of Humana in a research note on Wednesday, May 13th. William Blair assumed coverage on shares of Humana in a research note on Wednesday, May 20th. They issued an “outperform” rating for the company. Morgan Stanley raised their price objective on shares of Humana from $217.00 to $249.00 and gave the company an “underweight” rating in a research note on Thursday. Finally, Truist Financial raised their price objective on shares of Humana from $270.00 to $320.00 and gave the company a “hold” rating in a research note on Monday. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, fourteen have issued a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat, Humana currently has a consensus rating of “Hold” and an average target price of $279.30.

Hedge Funds Weigh In On Humana

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Montag A & Associates Inc. raised its position in Humana by 1,880.0% during the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after acquiring an additional 94 shares during the last quarter. CoreCap Advisors LLC raised its position in Humana by 54.4% during the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 37 shares during the last quarter. Fideuram Asset Management Ireland dac acquired a new position in Humana during the fourth quarter worth about $27,000. Reflection Asset Management acquired a new position in Humana during the fourth quarter worth about $29,000. Finally, Rosenberg Matthew Hamilton raised its position in Humana by 136.0% during the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock worth $30,000 after acquiring an additional 68 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Trading Down 1.2%

The firm has a market capitalization of $41.48 billion, a PE ratio of 36.98, a P/E/G ratio of 1.87 and a beta of 0.76. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66. The business’s fifty day moving average price is $244.92 and its 200 day moving average price is $231.58.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, topping analysts’ consensus estimates of $9.97 by $0.34. The business had revenue of $39.65 billion during the quarter, compared to the consensus estimate of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The company’s quarterly revenue was up 23.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, analysts expect that Humana Inc. will post 9 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, June 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.0%. Humana’s payout ratio is 37.86%.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.